Neoadjuvant chemotherapy modifies serum pyrrolidone carboxypeptidase specific activity in women with breast cancer and influences circulating levels of GnRH and gonadotropins

Ramírez-Expósito, María JesúsMartínez-Martos, Jose ManuelDueñas-Rodriguez, BasilioNavarro-Cecilia, JuliaCarrera-González, María del Pilar2024-02-022024-02-022020-06-06Ramírez-Expósito MJ, Martínez-Martos JM, Dueñas-Rodríguez B, Navarro-Cecilia J, Carrera-González MP. Neoadjuvant chemotherapy modifies serum pyrrolidone carboxypeptidase specific activity in women with breast cancer and influences circulating levels of GnRH and gonadotropins. Breast Cancer Res Treat. 2020 Aug;182(3):751-760.10.1007/s10549-020-05723-1https://hdl.handle.net/10953/1935engAtribución-NoComercial-SinDerivadas 3.0 Españahttp://creativecommons.org/licenses/by-nc-nd/3.0/es/Breast cancerNeoadjuvantMenopauseGonadotropinsPyrrolidone carboxypeptidaseNeoadjuvant chemotherapy modifies serum pyrrolidone carboxypeptidase specific activity in women with breast cancer and influences circulating levels of GnRH and gonadotropinsinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccess